26:2L-3. Definitions
As used in this act:
a. "Board" means the Therapeutic Research Qualification Review Board established in section 5 of this act.
b. "Commissioner" means the State Commissioner of Health.
c. "Schedule I controlled dangerous substance" means a controlled dangerous substance having a high addiction liability; no accepted medical use in the United States; and listed in New Jersey Administrative Code 8:65-10.1.
d. "Drugs" means drugs as defined in section 2 of P.L.1970, c. 226 (C. 24:21-2).
e. "Practitioner" means a physician licensed to prescribe and administer drugs which are subject to the "New Jersey Controlled Dangerous Substances Act" (P.L.1970, c. 226).
f. "Program" means the controlled dangerous substances therapeutic research program established in this act.
L.1981, c. 72, s. 3, eff. March 23, 1981.
a. "Board" means the Therapeutic Research Qualification Review Board established in section 5 of this act.
b. "Commissioner" means the State Commissioner of Health.
c. "Schedule I controlled dangerous substance" means a controlled dangerous substance having a high addiction liability; no accepted medical use in the United States; and listed in New Jersey Administrative Code 8:65-10.1.
d. "Drugs" means drugs as defined in section 2 of P.L.1970, c. 226 (C. 24:21-2).
e. "Practitioner" means a physician licensed to prescribe and administer drugs which are subject to the "New Jersey Controlled Dangerous Substances Act" (P.L.1970, c. 226).
f. "Program" means the controlled dangerous substances therapeutic research program established in this act.
L.1981, c. 72, s. 3, eff. March 23, 1981.
